Global Radiotheranostics Market Size study & Forecast, by Radioisotope (Iodine-131, Iodine-123, Gallium-68, Lutetium-177, 18F with Y-90, Others), by Approach (Targeted Therapeutic, Targeted Diagnostic), by Application (Oncology, Non Oncology) by and Regional Analysis, 2023-2030
Global Radiotheranostics Market is valued at approximately USD 7.51 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.49% over the forecast period 2023-2030. Radiotheranostics refers to the field of medicine that combine the therapeutic and diagnostic application of radiopharmaceuticals enabling personalized treatment strategies by using targeted radiation therapy and imaging techniques. The Radiotheranostics market is being driven by factors such as the Increasing prevalence of cancer cases and the rising adoption of injectable radiopharmaceuticals.
Radiotheranostics offers a personalized and targeted approach to cancer management. By combining diagnostic imaging with therapeutic interventions, it enhances precision, improves treatment outcomes, reduces side effects, and enables personalized therapies based on individual patients' characteristics and disease biology.According to the International Agency for Research on Cancer, Worldwide, an estimated 17 million new cancer cases in 2018 and it is estimated to rise by 27.5 million new cancer cases in 2040. Thus, rising in cancer cases fueling the market growth. In addition, increasing the approvals of new radiotheranostics agents and increasing public-private funding for research may create lucrative opportunities for the market. However, market expansion may hinder due to the high cost involved in research and development.
The key regions considered for the Global RadiotheranosticsMarket study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America holds the major share in radio theranostics market due to the rising overweight population and also rising adoption of large number of market players. Asia Pacific consider fastest growing market due to its large patient base and high investing nuclear medicine along with that rising orevlance of cancer.
Major market player included in this report are:
Novartis AG
Bayer AG
Progenics Pharmaceuticals, Inc.( Lantheus)
Telix Pharmaceuticals Limited.
ITM Isotope Technologies Munich SE
Life Molecular Imaging.
RadioMedix Inc.
IsoTherapeutics Group, LLC
Q BioMed Inc.
Nordic Nanovector ASA
Recent Developments in the Market:
On May 2022, Transcode therapeutics Inc. announced the execution of an option agreement under which transcode will have the right to negotiate an exclusive, world, royalty-bearing licence for a radiotheranostic technology disclosed in patent application PCT/US2021/057912 Entitled THERAPEUTICS, RADIOLABLED NANOPARTICLES AND METHOD OF USE THEREOF.
On Oct 2022, Clarity pharmaceuticals announced that the first patient in its phase1/2theranostic trial, which is testing 64Cu/67Cu SAR-bisPSMA theranostic product in people with metastatic castrate-restant prostate cancer, has been given a dose. The promising preclinical and clinical result so far support clarity’s investigation of the optimised SAR-bisPSMA product in additional oncology indications where the theranostic approach may be useful.
Global RadiotheranosticsMarket Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Radioisotope, Approach, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Radioisotope:
Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F with Y-90
Others
By Approach:
Targeted Therapeutic
Targeted Diagnostic
Application:
Oncology
Non Oncology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Radiotheranostics offers a personalized and targeted approach to cancer management. By combining diagnostic imaging with therapeutic interventions, it enhances precision, improves treatment outcomes, reduces side effects, and enables personalized therapies based on individual patients' characteristics and disease biology.According to the International Agency for Research on Cancer, Worldwide, an estimated 17 million new cancer cases in 2018 and it is estimated to rise by 27.5 million new cancer cases in 2040. Thus, rising in cancer cases fueling the market growth. In addition, increasing the approvals of new radiotheranostics agents and increasing public-private funding for research may create lucrative opportunities for the market. However, market expansion may hinder due to the high cost involved in research and development.
The key regions considered for the Global RadiotheranosticsMarket study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America holds the major share in radio theranostics market due to the rising overweight population and also rising adoption of large number of market players. Asia Pacific consider fastest growing market due to its large patient base and high investing nuclear medicine along with that rising orevlance of cancer.
Major market player included in this report are:
Novartis AG
Bayer AG
Progenics Pharmaceuticals, Inc.( Lantheus)
Telix Pharmaceuticals Limited.
ITM Isotope Technologies Munich SE
Life Molecular Imaging.
RadioMedix Inc.
IsoTherapeutics Group, LLC
Q BioMed Inc.
Nordic Nanovector ASA
Recent Developments in the Market:
On May 2022, Transcode therapeutics Inc. announced the execution of an option agreement under which transcode will have the right to negotiate an exclusive, world, royalty-bearing licence for a radiotheranostic technology disclosed in patent application PCT/US2021/057912 Entitled THERAPEUTICS, RADIOLABLED NANOPARTICLES AND METHOD OF USE THEREOF.
On Oct 2022, Clarity pharmaceuticals announced that the first patient in its phase1/2theranostic trial, which is testing 64Cu/67Cu SAR-bisPSMA theranostic product in people with metastatic castrate-restant prostate cancer, has been given a dose. The promising preclinical and clinical result so far support clarity’s investigation of the optimised SAR-bisPSMA product in additional oncology indications where the theranostic approach may be useful.
Global RadiotheranosticsMarket Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Radioisotope, Approach, Application, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Radioisotope:
Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F with Y-90
Others
By Approach:
Targeted Therapeutic
Targeted Diagnostic
Application:
Oncology
Non Oncology
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Radiotheranostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Radiotheranostics Market, by Radioisotope, 2020-2030 (USD Billion)
1.2.3. Radiotheranostics Market, by Approach, 2020-2030 (USD Billion)
1.2.4. Radiotheranostics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RADIOTHERANOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RADIOTHERANOSTICS MARKET DYNAMICS
3.1. Radiotheranostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer cases.
3.1.1.2. Rising adoption of injectable radiopharmaceuticals.
3.1.2. Market Challenges
3.1.2.1. High cost involved in research and development.
3.1.3. Market Opportunities
3.1.3.1. Increasing the approvals of new radiotheranostics agents.
3.1.3.2. Increasing public-private funding for research and development.
CHAPTER 4. GLOBAL RADIOTHERANOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE
5.1. Market Snapshot
5.2. Global Radiotheranostics Market by Radioisotope, Performance - Potential Analysis
5.3. Global Radiotheranostics Market Estimates & Forecasts by Radioisotope 2020-2030 (USD Billion)
5.4. Radiotheranostics Market, Sub Segment Analysis
5.4.1. Iodine-131
5.4.2. Iodine-123
5.4.3. Gallium-68
5.4.4. Lutetium-177
5.4.5. 18F with Y-90
5.4.6. Others
CHAPTER 6. GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH
6.1. Market Snapshot
6.2. Global Radiotheranostics Market by Approach, Performance - Potential Analysis
6.3. Global Radiotheranostics Market Estimates & Forecasts by Approach 2020-2030 (USD Billion)
6.4. Radiotheranostics Market, Sub Segment Analysis
6.4.1. Targeted therapeutic
6.4.2. Targeted Diagnostic
CHAPTER 7. GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Radiotheranostics Market by Application, Performance - Potential Analysis
7.3. Global Radiotheranostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Radiotheranostics Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Non-oncology
CHAPTER 8. GLOBAL RADIOTHERANOSTICS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Radiotheranostics Market, Regional Market Snapshot
8.4. North America Radiotheranostics Market
8.4.1. U.S. Radiotheranostics Market
8.4.1.1. Radioisotope breakdown estimates & forecasts, 2020-2030
8.4.1.2. Approach breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Radiotheranostics Market
8.5. Europe Radiotheranostics Market Snapshot
8.5.1. U.K. Radiotheranostics Market
8.5.2. Germany Radiotheranostics Market
8.5.3. France Radiotheranostics Market
8.5.4. Spain Radiotheranostics Market
8.5.5. Italy Radiotheranostics Market
8.5.6. Rest of Europe Radiotheranostics Market
8.6. Asia-Pacific Radiotheranostics Market Snapshot
8.6.1. China Radiotheranostics Market
8.6.2. India Radiotheranostics Market
8.6.3. Japan Radiotheranostics Market
8.6.4. Australia Radiotheranostics Market
8.6.5. South Korea Radiotheranostics Market
8.6.6. Rest of Asia Pacific Radiotheranostics Market
8.7. Latin America Radiotheranostics Market Snapshot
8.7.1. Brazil Radiotheranostics Market
8.7.2. Mexico Radiotheranostics Market
8.8. Middle East & Africa Radiotheranostics Market
8.8.1. Saudi Arabia Radiotheranostics Market
8.8.2. South Africa Radiotheranostics Market
8.8.3. Rest of Middle East & Africa Radiotheranostics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. Progenics Pharmaceuticals Inc.
9.3.4. Telix Pharmaceuticals
9.3.5. ITM Isotope Technologies Munich SE
9.3.6. Life molecular imaging
9.3.7. Radiomedix Inc.
9.3.8. Iso Therapeutics Group,LLC
9.3.9. Q Bio med Inc.
9.3.10. Nordic nanovector ASA
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Radiotheranostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Radiotheranostics Market, by Radioisotope, 2020-2030 (USD Billion)
1.2.3. Radiotheranostics Market, by Approach, 2020-2030 (USD Billion)
1.2.4. Radiotheranostics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL RADIOTHERANOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL RADIOTHERANOSTICS MARKET DYNAMICS
3.1. Radiotheranostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of cancer cases.
3.1.1.2. Rising adoption of injectable radiopharmaceuticals.
3.1.2. Market Challenges
3.1.2.1. High cost involved in research and development.
3.1.3. Market Opportunities
3.1.3.1. Increasing the approvals of new radiotheranostics agents.
3.1.3.2. Increasing public-private funding for research and development.
CHAPTER 4. GLOBAL RADIOTHERANOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE
5.1. Market Snapshot
5.2. Global Radiotheranostics Market by Radioisotope, Performance - Potential Analysis
5.3. Global Radiotheranostics Market Estimates & Forecasts by Radioisotope 2020-2030 (USD Billion)
5.4. Radiotheranostics Market, Sub Segment Analysis
5.4.1. Iodine-131
5.4.2. Iodine-123
5.4.3. Gallium-68
5.4.4. Lutetium-177
5.4.5. 18F with Y-90
5.4.6. Others
CHAPTER 6. GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH
6.1. Market Snapshot
6.2. Global Radiotheranostics Market by Approach, Performance - Potential Analysis
6.3. Global Radiotheranostics Market Estimates & Forecasts by Approach 2020-2030 (USD Billion)
6.4. Radiotheranostics Market, Sub Segment Analysis
6.4.1. Targeted therapeutic
6.4.2. Targeted Diagnostic
CHAPTER 7. GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Radiotheranostics Market by Application, Performance - Potential Analysis
7.3. Global Radiotheranostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Radiotheranostics Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Non-oncology
CHAPTER 8. GLOBAL RADIOTHERANOSTICS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Radiotheranostics Market, Regional Market Snapshot
8.4. North America Radiotheranostics Market
8.4.1. U.S. Radiotheranostics Market
8.4.1.1. Radioisotope breakdown estimates & forecasts, 2020-2030
8.4.1.2. Approach breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Radiotheranostics Market
8.5. Europe Radiotheranostics Market Snapshot
8.5.1. U.K. Radiotheranostics Market
8.5.2. Germany Radiotheranostics Market
8.5.3. France Radiotheranostics Market
8.5.4. Spain Radiotheranostics Market
8.5.5. Italy Radiotheranostics Market
8.5.6. Rest of Europe Radiotheranostics Market
8.6. Asia-Pacific Radiotheranostics Market Snapshot
8.6.1. China Radiotheranostics Market
8.6.2. India Radiotheranostics Market
8.6.3. Japan Radiotheranostics Market
8.6.4. Australia Radiotheranostics Market
8.6.5. South Korea Radiotheranostics Market
8.6.6. Rest of Asia Pacific Radiotheranostics Market
8.7. Latin America Radiotheranostics Market Snapshot
8.7.1. Brazil Radiotheranostics Market
8.7.2. Mexico Radiotheranostics Market
8.8. Middle East & Africa Radiotheranostics Market
8.8.1. Saudi Arabia Radiotheranostics Market
8.8.2. South Africa Radiotheranostics Market
8.8.3. Rest of Middle East & Africa Radiotheranostics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Novartis AG
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. Progenics Pharmaceuticals Inc.
9.3.4. Telix Pharmaceuticals
9.3.5. ITM Isotope Technologies Munich SE
9.3.6. Life molecular imaging
9.3.7. Radiomedix Inc.
9.3.8. Iso Therapeutics Group,LLC
9.3.9. Q Bio med Inc.
9.3.10. Nordic nanovector ASA
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Radiotheranostics Market, report scope
TABLE 2. Global Radiotheranostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Radiotheranostics Market estimates & forecasts by Radioisotope 2020-2030 (USD Billion)
TABLE 4. Global Radiotheranostics Market estimates & forecasts by Approach 2020-2030 (USD Billion)
TABLE 5. Global Radiotheranostics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Radiotheranostics Market
TABLE 71. List of primary sources, used in the study of global Radiotheranostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Radiotheranostics Market, report scope
TABLE 2. Global Radiotheranostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Radiotheranostics Market estimates & forecasts by Radioisotope 2020-2030 (USD Billion)
TABLE 4. Global Radiotheranostics Market estimates & forecasts by Approach 2020-2030 (USD Billion)
TABLE 5. Global Radiotheranostics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 6. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Radiotheranostics Market
TABLE 71. List of primary sources, used in the study of global Radiotheranostics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Radiotheranostics Market, research methodology
FIG 2. Global Radiotheranostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Radiotheranostics Market, key trends 2022
FIG 5. Global Radiotheranostics Market, growth prospects 2023-2030
FIG 6. Global Radiotheranostics Market, porters 5 force model
FIG 7. Global Radiotheranostics Market, pest analysis
FIG 8. Global Radiotheranostics Market, value chain analysis
FIG 9. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Radiotheranostics Market, regional snapshot 2020 & 2030
FIG 15. North America Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Radiotheranostics Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Radiotheranostics Market, research methodology
FIG 2. Global Radiotheranostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Radiotheranostics Market, key trends 2022
FIG 5. Global Radiotheranostics Market, growth prospects 2023-2030
FIG 6. Global Radiotheranostics Market, porters 5 force model
FIG 7. Global Radiotheranostics Market, pest analysis
FIG 8. Global Radiotheranostics Market, value chain analysis
FIG 9. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Radiotheranostics Market, regional snapshot 2020 & 2030
FIG 15. North America Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Radiotheranostics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Radiotheranostics Market 2020 & 2030 (USD Billion)
List of tables and figures are dummy in nature, final lists may vary in the final deliverable
